BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492 AND Diagnosis
4 results:

  • 1. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of calm as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.
    Meng H; Zhu X; Li L; Liang Z; Li X; Pan X; Zeng F; Qu S
    Int J Mol Med; 2017 Oct; 40(4):1152-1164. PubMed ID: 28849027
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules.
    Singer J; Hanna JW; Visaria J; Gu T; McCoy M; Kloos RT
    Curr Med Res Opin; 2016 Jul; 32(7):1225-32. PubMed ID: 26973059
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [head and neck cancer patients' experiences with accelerated diagnostic and treatment programs].
    Junge AG; Risør MB; Toustrup K; Grau C
    Ugeskr Laeger; 2010 Jan; 172(4):274-8. PubMed ID: 20105393
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.